A Trial Has a Protocol but No Posted Results: How to Trace Its Status

By ClinicalStudyConnect.com Research Desk

If you found a registered trial with a full protocol — design, population, dosing, outcome measures — but no results posted, the short answer is: check three dates and one status field before assuming anything went wrong. Look at the study’s Recruitment Status, its Primary Completion Date, and whether it was ever flagged as an Applicable Clinical Trial (ACT) subject to mandatory reporting. Missing results can mean the trial is still running, still inside its legal reporting window, delayed under an approved certification, or simply not required to report on that registry at all. It rarely means the data vanished or that anyone did anything improper — but it does mean you cannot yet draw conclusions from that trial, and you should treat its “unpublished” status as a data point, not a verdict.

Why a Protocol Can Sit There With No Results for Years

A trial record on a public registry like ClinicalTrials.gov is built in stages, and the protocol is posted long before any outcome data exists. Registration happens near the start of the study — often before a single participant is enrolled — while results, when they are posted, arrive only after the trial reaches specific milestones. Between those two events, a study can spend months or years showing a complete protocol and an empty “Study Results” tab. That gap is normal by design, not a red flag on its own.

The registry’s own study-record guidance is a useful starting point for seeing what fields exist on a record and what stage each one is tracking (ClinicalTrials.gov: How to Read a Study Record).

The Two Dates That Actually Answer the Question

Two dates on the record matter more than any other field when you’re trying to work out whether results are “late,” “not due yet,” or “not required”:

• Primary Completion Date — the date the last participant completed the last visit or procedure tied to the trial’s main outcome measure. This is the date the reporting clock starts from, not the date the whole study wraps up.
• Study Completion Date — the date the entire trial concluded, including any secondary or long-term follow-up. Some trials keep collecting data long after their primary outcome is settled, so this date can sit well after results for the primary outcome were already due.

Under the FDAAA Final Rule, a study classified as an Applicable Clinical Trial (ACT) is generally required to submit results within roughly one year of its Primary Completion Date — commonly described as a 12-month window, with about a 30-day administrative buffer built into how it’s enforced (UNC Office of Clinical Trials: ClinicalTrials.gov Reporting; Bennett Institute for Applied Data Science: Why Is This Trial Due to Report?). So the first practical check is simple: has it even been a year since the Primary Completion Date? If not, an empty results tab tells you nothing beyond “not due yet.”

Not Every Trial Has to Report Results at All

A second reason a protocol can sit with no results indefinitely: the trial may never have been required to post them in the first place. The reporting mandate applies specifically to studies meeting the “applicable clinical trial” definition — broadly, interventional studies of drugs, biologics, devices, and similar FDA-regulated interventions, with two notable carve-outs: trials in Phase 1 are excluded, and studies whose primary purpose is classified as “Device Feasibility” are excluded. Studies that don’t meet the applicable-trial definition at all — including many observational studies and trials of interventions outside FDA’s regulatory reach — can be registered on the same public database without any legal results-reporting deadline attached (Bennett Institute: Why Is This Trial Due to Report?).

That distinction matters because it means “no results posted” and “overdue results” are not the same finding. Confirming which category a trial falls into is a required step before treating a missing results tab as noteworthy.

Legitimate Delays Also Exist

Even among trials that are required to report, the deadline can be legitimately extended. A responsible party can submit a certification in support of delayed posting of results — available when the product under study is not yet approved and development is still active, or is approved but is being studied for a new use. A trial sitting past the standard one-year mark with no results is not automatically in violation; it may be operating under an on-record certification like this one (Troutman Pepper Locke: FDA Enforces ClinicalTrials.gov Results Posting Requirements).

Two Different Reporting Standards Are at Play

Part of what makes trial status confusing is that “protocol” and “results” are governed by two separate reporting frameworks, built for two different stages of a trial. SPIRIT (Standard Protocol Items: Recommendations for Interventional Trials) sets out what a complete, transparent protocol should contain before a trial enrolls anyone. CONSORT (Consolidated Standards of Reporting Trials) sets out what a complete results report should contain once a trial concludes. A trial can fully satisfy SPIRIT-level protocol transparency and still be nowhere near a CONSORT-level results report, simply because those two checklists apply at different points in the trial’s timeline (CONSORT-SPIRIT: Reporting Guidelines for Clinical Trials). Recognizing that a thorough protocol is not itself evidence that results are imminent is part of reading these records accurately.

A Results Trace Checklist

Use this sequence on any registered trial where you can see the protocol but not the outcome data:

1. Read the Recruitment Status field first. A status of “Recruiting,” “Active, not recruiting,” or “Not yet recruiting” tells you the trial likely hasn’t reached completion at all — results aren’t expected yet regardless of how old the protocol looks.
2. Find the Primary Completion Date, not the Completion Date. These are frequently different, and the reporting clock runs from the earlier, primary-outcome-specific date.
3. Calculate the time elapsed since that date. Under one year, an empty results tab is expected. Past one year, move to the next step.
4. Check whether the study is flagged as an Applicable Clinical Trial. If it isn’t, there is no legal reporting deadline to be “overdue” against — treat the missing results as a registry limitation, not a compliance issue.
5. Look for an on-record certification of delayed posting. An approved certification explains a late-looking record without anything having gone wrong.
6. Search for the trial’s registry ID (its NCT number) outside the registry. Results are sometimes published first in a peer-reviewed journal, a conference abstract, or a sponsor announcement well before — or occasionally instead of — being entered into the registry’s own results database.
7. Check a public compliance tracker for context, not a verdict. Tools built specifically to flag overdue applicable trials, such as the FDAAA TrialsTracker, can show whether a given study has actually been identified as overdue rather than relying on a guess (Bennett Institute: FDAAA TrialsTracker).
8. Note what remains unresolved. If none of the above explains the gap, the honest conclusion is “status unresolved as of the date you checked” — not “results were suppressed” or “the trial failed.”

What This Does and Doesn’t Tell You

What’s established: registries separate protocol posting from results posting by design, a specific completion date starts a specific reporting clock, not all trials are legally required to report on that clock, and legitimate certified extensions exist. What remains genuinely uncertain from the registry alone: whether a specific trial’s silence reflects an ordinary in-progress status, an approved delay, a non-applicable classification, or an actual lapse — that requires working through the checklist above on the individual record, not inferring from the protocol’s completeness.

The next practical step is record-specific: pull up the trial’s own status field and dates rather than generalizing from how thorough its protocol reads. A well-written protocol is a signal about study design quality — it is not a signal about when, or whether, results will appear.

A Note on Limits

This walkthrough explains how public trial registries structure and time-stamp information; it is not medical advice and does not evaluate any specific product, treatment, or condition. Decisions about participating in a trial, interpreting a trial’s findings, or acting on a treatment should be made with a qualified clinician who can review the full record and your individual situation.

For related reading on how study design elements are reported and verified, see our Study Design section, and for a broader look at where clinical evidence has known gaps or limitations, see Safety & Limitations. More on how this publication approaches sourcing is on our About page.